The Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over
NCT02321449 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2019-01-11
Summary
To evaluate the effectiveness of treatment with Circadin based on sleep improvement as assessed by the modified Questionnaire Scoring Subjective Characteristics of Sleep before and after the treatment
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Medical Director · Ipsen
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
Countries
- Russia
Study Locations
More Related Trials
-
Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
NCT00972075 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
NCT01906866 ·Status: COMPLETED ·Phase: PHASE3
-
Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly
NCT02648776 ·Status: UNKNOWN
-
Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients
NCT02087722 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Melatonin and Zolpidem Effect on Postural Instability in Healthy Adult Subjects
NCT01280734 ·Status: COMPLETED ·Phase: PHASE4
-
Study for Evaluating the Efficacy of Ciprofol in Patients Under Narcotic Sleep With Chronic Insomnia
NCT04958382 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the Elderly
NCT00295386 ·Status: COMPLETED ·Phase: PHASE4
-
Appraising Clinical Trial Experiences of Patients With Insomnia
NCT05978271 ·Status: NOT_YET_RECRUITING
-
Insomnia Behavioral Intervention Study
NCT05301543 ·Status: RECRUITING ·Phase: NA
-
Insomnia in Older Adults: Impact of Personalized, Diet-Induced Alterations in the Microbiota
NCT03085446 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder
NCT03545191 ·Status: COMPLETED ·Phase: PHASE3
-
Suvorexant and Sleep/Delirium in ICU Patients
NCT04092894 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.
NCT06584513 ·Status: RECRUITING ·Phase: NA
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
NCT01995838 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
NCT03575104 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Blinded Tapering for Hypnotic Discontinuation
NCT04050176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder
NCT03056053 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects
NCT03892902 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Suvorexant on Post-operative Sleep Disturbance
NCT05823844 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year
NCT00253903 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances
NCT01903681 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Trazodone to Treat Insomnia in Older Adults (TRADITION Study)
NCT06983080 ·Status: RECRUITING ·Phase: PHASE2
-
A Sleep-Oriented Intervention for Suicidal Behaviors
NCT01770587 ·Status: COMPLETED ·Phase: NA
-
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia
NCT06053840 ·Status: COMPLETED ·Phase: PHASE4
-
Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT05838430 ·Status: COMPLETED ·Phase: PHASE4